As companies roll out data showing the power and improved safety profile of antibodies that target two antigens, analysts say ...

Allowing patients to stay in their homes to receive bispecific antibodies can make the whole cancer journey easier, explained ...

A poll of experts revealed that few are utilizing talquetamab for patients with pretreated relapsed/refractory myeloma.

In an interview with Targeted Oncology, Omar Nadeem, MD, discussed the first results from the Immuno-PRISM study in patients ...

Researchers from Shanghai Institute of Biological Products Co. Ltd. published details on the development and preclinical characterization of novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 ...

Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today announced a poster regarding the Company’s clinical ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

ImmunoPrecise Antibodies, an AI-driven biotherapeutic research and technology company, has entered into a material transfer ...

In an interview with Targeted Oncology, Courtney Van Houzen, PharmD, shared her experience in bringing bispecific antibody ...

Global Bispecific Antibody Market Size Bispecific Antibodies Sales FDA Approved Bispecific Antibodies Market Forecast ...

Q3 2024 Earnings Call Transcript October 15, 2024 Johnson & Johnson beats earnings expectations. Reported EPS is $2.42, ...

"Adimab has been the undisputed industry leader for well over a decade and the breadth and depth of their technology and expertise is unparalleled," said Dr. Sato. "I am thrilled to join them and in ...